Joint development with Kyushu University of a leave-of-absence and return-to-work support system
First written in FY2022. 1 of 3 entries say "Restated". Latest entry: FY2024.
No other company in this theme has enough history to compare yet.
- FY2024AdvancedAnnual report
「Our company; National University Corporation Kyushu University; Japan; joint research agreement; 27 June 2022; from 1 July 2022 to 30 June 2025; development of a system supporting leave of absence and return to work, using depression biomarkers (multiple biomarkers) as evaluation indicators.」
The joint research agreement for the system supporting leave of absence and return to work using depression biomarkers has continued, with the contract period running through 30 June 2025. - FY2023RestatedAnnual report
「Our company; National University Corporation Kyushu University; Japan; joint research agreement; 27 June 2022; from 1 July 2022 to 30 September 2023; development of a system supporting leave of absence and return to work, using depression biomarkers (multiple biomarkers) as evaluation indicators.」
The joint development of a system supporting leave of absence and return to work using depression biomarkers has continued under a contract running through 30 September 2023. - FY2022First statedAnnual report
「Our company; National University Corporation Kyushu University; Japan; joint research agreement; 27 June 2022; from 1 July 2022 to 30 June 2023; development of a system supporting leave of absence and return to work, using depression biomarkers (multiple biomarkers) as evaluation indicators.」
The company entered into a joint development agreement with Kyushu University for a system supporting leave of absence and return to work, using multiple depression biomarkers as evaluation indicators.